DMEM/F12 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (16)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain. (2025)
- Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition. (2025)
- Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
- ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
- Single-cell genomic variation induced by mutational processes in cancer. (2022)
- AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. (2020)
- The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data. (2019)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- PGBD5 promotes site-specific oncogenic mutations in human tumors. (2017)
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. (2017)
- Spatial reconstruction of single-cell gene expression data. (2015)
- A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation. (2014)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. (2012)
- An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. (2009)
Merged raw entities (8)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| dmem/f12 | drug | 35 | 52 |
| dmem/f-12 | drug | 10 | 10 |
| dulbecco’s modified eagle’s medium | drug | 9 | 9 |
| dmem/f12 medium | drug | 5 | 5 |
| dmem/f12 (invitrogen) | drug | — | — |
| dulbecco's modified eagle medium/f-12 | drug | — | — |
| dulbecco's modified eagle medium/f12 | drug | — | — |
| dulbecco’s modified eagle’s medium /f12 | drug | — | — |